Sign in
CompletedNo phase

A User-friendly, Non-invasive Neuro-orthosis That Restores Volitionally Controlled Grasp Functions for SCI Survivors With Tetraplegia

Key facts

Who runs it
Ohio State University
Where
Columbus, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
12 people enrolled
Started
31 Oct 2023
Ended
11 May 2026
Type of study
Interventional
Treatments tested
  • NeuroLife EMG-FES Sleeve System
Record updated
26 May 2026

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • age 22 years or older
  • sustained a chronic (>12 months) cervical SCI (AIS A, B, C, or D) and is currently medically stable
  • unable to grasp and manipulate objects to allow independent performance of activities of daily living (e.g., Tetraplegia)
  • retain voluntary ability to enact unilateral shoulder and elbow movements either independently or with a mobile arm support
  • Willing and able to attend study sessions in Columbus, Ohio for 12 weeks, 3x/week and all assessment sessions (4 weeks prior to and 4 weeks following 12-week intervention protocol)
  • able to provide informed consent

Who cannot take part

  • medical contraindications to FES (e.g., pacemaker or other implanted devices, uncontrolled seizure disorder, cancer or open wounds on hands)
  • comorbid medical condition that, in the opinion of the PI, that may impact participant safety or study results
  • severe, uncontrolled autonomic dysreflexia
  • severe upper extremity spasticity or contractures that prevent FES-evoked wrist and finger movements
  • ventilator dependent
  • pregnant or plan to become pregnant (females only)
  • actively participating in upper extremity rehabilitation

Where in United States

  • Battelle Memorial InstituteColumbus, United States
  • Ohio State University Wexner Medical Center (Columbus Campus, Dodd Hall, Martha Morehouse Medical Pavillion)Columbus, United States

About the trial

What the trial wants to find out

The goal of this pilot clinical study is to investigate the NeuroLife EMG-FES Sleeve System, a closed-loop approach to functional electrical stimulation, in adults (n=12) with chronic (>12 months) tetraplegia due to spinal cord injury. Briefly, the NeuroLife EMG-FES System is a completely non-invasive system (surface electrodes only, no implantable components) worn on the forearm which has up to 160 electrodes that can record electromyography (EMG), or muscle activity, and also electrically stimulate (FES) muscles. The main questions this study aims to answer are: 1) What is the safety, feasibility, and early efficacy of the NeuroLife EMG-FES system on upper extremity outcomes in chronic SCI survivors with tetraplegia, and 2) Can EMG be used as a biomarker of recovery over time in chronic SCI participants undergoing rehabilitation? Participants will complete an intensive, task-oriented rehabilitation protocol using the NeuroLife EMG-FES System (3x/week x 12 weeks) in an outpatient setting. We will assess functional outcomes using standardized clinical measures of hand and arm function at six timepoints.

The group in the trial

  • NeuroLife EMG-FES Sleeve SystemTreatment being tested

    The NeuroLife EMG-FES System is a completely non-invasive system (surface electrodes only, no implantable components) worn on the forearm of participants and has up to 160 electrodes that can record electromyography (EMG), or muscle activity, and also electrically stimulate (FES) muscles. Using this combined, closed-loop technology participants will complete a 12-week protocol with a study therapist practicing functional activities using their hand/forearm while wearing the NeuroLife EMG-FES Sleeve System.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
26 May 2026